Akanda (NASDAQ:AKAN) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Akanda (NASDAQ:AKAN – Free Report) from a strong sell rating to a sell rating in a report published on Saturday.

Separately, Weiss Ratings downgraded shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, May 18th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Akanda has a consensus rating of “Sell”.

Get Akanda alerts:

Get Our Latest Analysis on AKAN

Akanda Trading Down 18.4%

Akanda stock opened at $6.31 on Friday. Akanda has a 52 week low of $2.30 and a 52 week high of $209.02. The business’s 50-day simple moving average is $14.73 and its 200-day simple moving average is $10.49.

Akanda (NASDAQ:AKAN – Get Free Report) last announced its earnings results on Tuesday, June 9th. The company reported ($317.90) earnings per share for the quarter.

Akanda Company Profile

(Get Free Report)

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Further Reading

• Five stocks we like better than Akanda
• AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
• Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
• Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
• Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight

Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.